Exploring novel therapeutic approaches for managing cardiovascular-kidney-metabolic syndrome: A review of pharmacological advancements
Authors:
- Durlav ChowdhuryDCDurlav Chowdhury
- Arunava MishraAMArunava Mishra
- Nidhi KumariNKNidhi Kumari
- Rahul MannaRMRahul Manna
- Ayandip SahooASAyandip Sahoo
- Pameshwar KumarPKPameshwar Kumar
- Surendra H. BodakheSBSurendra H. Bodakhe
- 22 April 2026
- journal article
- review article
- Published by Elsevier in Obesity Medicine
- Vol. 61
Abstract
No abstract availableThis publication has 128 references indexed in Scilit:
- SGLT-2 Inhibitors and GLP-1 Receptor Agonists as Combination Therapy in Type 2 DiabetesCurrent Diabetes Reports, 2026
- Triple Agonism Based Therapies for ObesityCurrent Cardiovascular Risk Reports, 2025
- Impact of Bariatric Metabolic Surgery on Cardiovascular, Kidney, and Mortality Outcomes Among Adults with Obesity and Chronic Kidney Disease Across Different Time FramesObesity Surgery, 2025
- Integrating Artificial Intelligence in the Diagnosis and Management of Metabolic Syndrome: A Comprehensive ReviewDiabetes/Metabolism Research and Reviews, 2025
- The effect of pharmacist‐led interventions on the management and outcomes in chronic kidney disease (CKD): A systematic review and meta‐analysis protocolHealth Science Reports, 2023
- Nonadherence to lipid‐lowering therapy and strategies to improve adherence in patients with atherosclerotic cardiovascular diseaseClinical Cardiology, 2022
- Potential Clinical Applications for Continuous Ketone Monitoring in the Hospitalized Patient with DiabetesCurrent Diabetes Reports, 2022
- The roles of collagen in chronic kidney disease and vascular calcificationJournal of Molecular Medicine, 2020
- Kidney Is Essential for Blood Pressure Modulation by Dietary PotassiumCurrent Cardiology Reports, 2020
- Nutrition in chronic heart failure patients: a systematic reviewHeart Failure Reviews, 2019